"Experts at the Rush Alzheimer’s Disease Center understand the physical and emotional toll the disease takes on patients and their families. They’re committed to discovering better ways to diagnose, treat and prevent Alzheimer’s and other dementias."

During the past decade, Rush Alzheimer's Disease Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rush Alzheimer's Disease Center" #1 sponsor was "Genentech, Inc." with 3 trials, followed by "Alzheimer's Disease Cooperative Study (ADCS)" with 2 trials sponsored, "Athira Pharma" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Hennepin Healthcare Research Institute" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rush Alzheimer's Disease Center" #1 collaborator was "National Institute on Aging (NIA)" with 5 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Berman Center for Outcomes and Clinical Research" with 2 trials as a collaborator, "Monash University" with 2 trials as a collaborator and "National Cancer Institute (NCI)" with 2 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Rush Alzheimer's Disease Center" are "Alzheimer's Disease" (9 trials), "Alzheimer Disease" (5 trials), "Cancer" (2 trials), "Dementia" (2 trials) and "Bleeding" (1 trials). Many other conditions were trialed in "Rush Alzheimer's Disease Center" in a lesser frequency.

Most popular intervention types in "Rush Alzheimer's Disease Center" are "Drug" (14 trials), "Behavioral" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "ATH-1017" (2 trials), "Solanezumab" (2 trials), "100 mg enteric-coated aspirin" (1 trials) and "Aricept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rush Alzheimer's Disease Center" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Rush Alzheimer's Disease Center". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in Rush Alzheimer's Disease Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Rush Alzheimer's Disease Center, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".